{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:39:45Z","timestamp":1778870385965,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jmii.2023.08.008","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T11:47:09Z","timestamp":1693568829000},"page":"1207-1213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan"],"prefix":"10.1016","volume":"56","author":[{"given":"Yi-Hsuan","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chih","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ren","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7885-1652","authenticated-orcid":false,"given":"Shih-Neng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuh-Lih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Tsung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jmii.2023.08.008_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"7900","key":"10.1016\/j.jmii.2023.08.008_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/d41586-022-00649-8","article-title":"Taiwan's pandemic vice-president - from lab bench to public office and back","volume":"603","author":"Chien-Jen","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jmii.2023.08.008_bib3","doi-asserted-by":"crossref","first-page":"869818","DOI":"10.3389\/fmed.2022.869818","article-title":"Identification and analysis of SARS-CoV-2 alpha variants in the largest Taiwan COVID-19 outbreak in 2021","volume":"9","author":"Liu","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"14","key":"10.1016\/j.jmii.2023.08.008_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.2020.3151","article-title":"Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.jmii.2023.08.008_bib5","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"issue":"10339","key":"10.1016\/j.jmii.2023.08.008_bib6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","article-title":"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jmii.2023.08.008_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2023.08.008_bib8","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https:\/\/www.covid19treatmentguidelines.nih.gov. Accessed 23 January 2023."},{"key":"10.1016\/j.jmii.2023.08.008_bib9","first-page":"1","article-title":"Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19","author":"Bhimraj","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jmii.2023.08.008_bib10","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/cid\/ciab536","article-title":"Improved survival among hospitalized patients with coronavirus disease 2019 (COVID-19) treated with remdesivir and dexamethasone. A nationwide population-based cohort study","volume":"73","author":"Benfield","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2023.08.008_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijid.2021.02.092","article-title":"A shorter symptom onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: a real-world analysis","volume":"106","author":"Mehta","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jmii.2023.08.008_bib12","first-page":"1","article-title":"Clinical outcomes of hospitalized COVID-19 patients treated with remdesivir: a retrospective analysis of a large tertiary care center in Germany","author":"Marx","year":"2022","journal-title":"Infection"},{"issue":"10","key":"10.1016\/j.jmii.2023.08.008_bib13","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/jac\/dkab256","article-title":"The association of remdesivir and in-hospital outcomes for COVID-19 patients treated with steroids","volume":"76","author":"Kuno","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jmii.2023.08.008_bib14","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1093\/cid\/ciab728","article-title":"Optimal timing of remdesivir initiation in hospitalized patients with coronavirus disease 2019 (COVID-19) administered with dexamethasone","volume":"75","author":"Wong","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8 Suppl 1","key":"10.1016\/j.jmii.2023.08.008_bib15","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1093\/ofid\/ofab466.746","article-title":"Risk factors associated with 30-day mortality in a large cohort of patients who received remdesivir and corticosteroids for severe COVID-19","author":"Gupta","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2023.08.008_bib16","series-title":"SARS-CoV-2 infection clinical management guideline","year":"2022"},{"issue":"13","key":"10.1016\/j.jmii.2023.08.008_bib17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jmii.2023.08.008_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.jmii.2023.08.008_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jmii.2023.08.008_bib20","doi-asserted-by":"crossref","first-page":"E242","DOI":"10.1503\/cmaj.211698","article-title":"Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial","volume":"194","author":"Ali","year":"2022","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"10334","key":"10.1016\/j.jmii.2023.08.008_bib21","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21","volume":"399","year":"2022","journal-title":"Lancet"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:30:11Z","timestamp":1761658211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118223001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1684118223001585"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2023.08.008","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2023.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}